专利信息

首页 1 2 3 4 5 6 下页尾页共 637 条记录, 当前第1/64页。

专利标题：Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad

专利权人：ELI LILLY AND COMPANY;

This invention provides a single-dose oral formulation of spinosad for the extended control of a C. felis infestation on a cat at a predictable dose of spinosad that is suitable for administration once every 30 days (i.e. one month). The invention also provides methods of using the formulation of spinosad.

专利标题：Crystalline forms of gemcitabine amide prodrug, compositions and use thereof

专利权人：ELI LILLY AND COMPANY;

The present invention relates to novel crystal forms of an amide prodrug of gemcitabine compositions thereof and methods for using.

专利标题：Pegylated insulin lispro compounds

专利权人：ELI LILLY AND COMPANY;

PEGYLATED INSULIN LISPRO COMPOUNDS Abstract The present invention relates to the field of diabetes. More particularly the 5 invention relates to PEGylated insulin lispro compounds that are PEGylated with high molecular weight poly(ethylene glycol) are highly soluble at physiological pH have an extended duration of action and characterized by pharmacokinetic pharmacodynamic and/or activity peak-trough ratios of less than 2. The invention also relates to methods of providing such molecules to phar...

专利标题：Pegylated insulin lispro compounds

专利权人：ELI LILLY AND COMPANY;

专利标题：Substituted [(5h-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity h1 inverse agonists/5-ht2a antagonists

专利权人：ELI LILLY AND COMPANY;

A dual H1/5-HT2A receptor antagonist of the formula: its uses and methods for its preparation are described.

专利标题：Substituted [(5h-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity h1 inverse agonists/5-ht2a antagonists

专利权人：ELI LILLY AND COMPANY;

A dual H1/5-HT2A receptor antagonist of the formula: its uses and methods for its preparation are described.

专利标题：2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-ht7 receptor antagonists

专利权人：ELI LILLY AND COMPANY;

The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine persistent pain and anxiety: where A and B are each independently —C(H)═ or —N═ provided that at least one of A and B is —N═ n is 1-3 m is 0-3 and R1-4 are as defined herein.

专利标题：Pegylerede insulin-lispro-forbindelser

专利权人：ELI LILLY AND COMPANY;

专利标题：Pegylierte insulin-lispro-verbindungen

专利权人：ELI LILLY AND COMPANY;

专利标题：Pegylated insulin lispro compounds

专利权人：ELI LILLY AND COMPANY;

当前查询条件: [IPC] 包含 'A' AND [专利权人] 包含 'ELI LILLY AND COMPANY'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US20140031306A1	2014/1/30
专利标题：Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad 专利权人：ELI LILLY AND COMPANY; This invention provides a single-dose oral formulation of spinosad for the extended control of a C. felis infestation on a cat at a predictable dose of spinosad that is suitable for administration once every 30 days (i.e. one month). The invention also provides methods of using the formulation of spinosad.

2. EP2043653B1	2013/12/25
专利标题：Crystalline forms of gemcitabine amide prodrug, compositions and use thereof 专利权人：ELI LILLY AND COMPANY; The present invention relates to novel crystal forms of an amide prodrug of gemcitabine compositions thereof and methods for using.

3. AU2011235959C1	2013/10/10	AU20110235959	2011/10/11
专利标题：Pegylated insulin lispro compounds 专利权人：ELI LILLY AND COMPANY; PEGYLATED INSULIN LISPRO COMPOUNDS Abstract The present invention relates to the field of diabetes. More particularly the 5 invention relates to PEGylated insulin lispro compounds that are PEGylated with high molecular weight poly(ethylene glycol) are highly soluble at physiological pH have an extended duration of action and characterized by pharmacokinetic pharmacodynamic and/or activity peak-trough ratios of less than 2. The invention also relates to methods of providing such molecules to phar...

4. AU2011235959B2	2013/3/21	AU20110235959	2011/10/11
专利标题：Pegylated insulin lispro compounds 专利权人：ELI LILLY AND COMPANY; PEGYLATED INSULIN LISPRO COMPOUNDS Abstract The present invention relates to the field of diabetes. More particularly the 5 invention relates to PEGylated insulin lispro compounds that are PEGylated with high molecular weight poly(ethylene glycol) are highly soluble at physiological pH have an extended duration of action and characterized by pharmacokinetic pharmacodynamic and/or activity peak-trough ratios of less than 2. The invention also relates to methods of providing such molecules to phar...

5. US8314092B2	2012/11/20
专利标题：Substituted [(5h-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity h1 inverse agonists/5-ht2a antagonists 专利权人：ELI LILLY AND COMPANY; A dual H1/5-HT2A receptor antagonist of the formula: its uses and methods for its preparation are described.

6. US20120202797A1	2012/8/9
专利标题：Substituted [(5h-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity h1 inverse agonists/5-ht2a antagonists 专利权人：ELI LILLY AND COMPANY; A dual H1/5-HT2A receptor antagonist of the formula: its uses and methods for its preparation are described.

7. US8202873B2	2012/6/19
专利标题：2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-ht7 receptor antagonists 专利权人：ELI LILLY AND COMPANY; The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine persistent pain and anxiety: where A and B are each independently —C(H)═ or —N═ provided that at least one of A and B is —N═ n is 1-3 m is 0-3 and R1-4 are as defined herein.

8. DK2288375T3	2012/5/21	DK20090763419T	2009/6/9
专利标题：Pegylerede insulin-lispro-forbindelser 专利权人：ELI LILLY AND COMPANY;

9. AT554786T	2012/5/15	AT20090763419T	2009/6/9
专利标题：Pegylierte insulin-lispro-verbindungen 专利权人：ELI LILLY AND COMPANY;

10. EP2288375B1	2012/4/25	EP20090763419	2009/6/9
专利标题：Pegylated insulin lispro compounds 专利权人：ELI LILLY AND COMPANY;

下载范围

下载内容